[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337066-105":59,"doc-detail-337066-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","integrated-analyses-of-multi-omic-data-derived-from-paired-primary-lung-cancer-and-brain-metastasis-research-open-access","Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis - research open access","","Lung cancer brain metastases (LC-BrMs) are linked to poor outcomes, yet effective standard-of-care treatments remain limited. This study integrates genomic, transcriptomic, proteomic, metabolomic, and single-cell RNA sequencing data from 154 patients across bulk and single-cell cohorts, including paired and unpaired primary lung cancer and LC-BrM samples. Results show increased intra-tumor heterogeneity, shared driver mutations, and similar copy-number landscapes with focal amplifications enriched in LC-BrMs. Mechanistically, mitochondrial-specific metabolism is activated while the tumor immune microenvironment is suppressed, with therapeutic vulnerability to oxidative phosphorylation using gamitrinib, enhanced by anti-PD-1.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrated-analyses-of-multi-omic-data-derived-from-paired-primary-lung-cancer-and-brain-metastasis-research-open-access/337066/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrated-analyses-of-multi-omic-data-derived-from-paired-primary-lung-cancer-and-brain-metastasis-research-open-access/337066.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in lung cancer brain metastases?","Question",{"text":112,"@type":113},"The study addresses the poor mortality associated with LC-BrMs and the limited efficacy of current standard-of-care therapies, emphasizing the need for better mechanistic understanding to enable new therapeutics.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What types of data were integrated, and how many patient samples were used?",{"text":117,"@type":113},"The authors performed integrated analyses of genomic, transcriptomic, proteomic, metabolomic, and single-cell RNA sequencing data from 154 patients, using four published and two newly generated patient cohorts across bulk and single-cell levels.",{"name":119,"@type":110,"acceptedAnswer":120},"What major biological findings were reported for LC-BrMs?",{"text":121,"@type":113},"LC-BrMs showed greater intra-tumor heterogeneity, shared key mutations between primary tumors and metastases, and similar genome-wide copy-number landscapes with focal amplifications enriched in LC-BrMs. Integrated omics suggested activated mitochondrial-specific metabolism alongside suppressed tumor immune microenvironments.",{"name":123,"@type":110,"acceptedAnswer":124},"How did the proposed therapeutic approach perform experimentally?",{"text":125,"@type":113},"Targeting oxidative phosphorylation with gamitrinib in patient-derived organoids induced apoptosis and reduced proliferation. The combination of gamitrinib plus anti-PD-1 immunotherapy improved survival in mice bearing LC-BrMs.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},337066,1790714403,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Duan etal. Genome Medicine (2024) 16:138 [https://doi.org/10.1186/s13073-024-01410-8](https://doi.org/10.1186/s13073-024-01410-8)  \nGenome Medicine  \n RESEARCH Open Access  \nIntegrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target  \nHao Duan1†, Jianlan Ren2†, Shiyou Wei3†, Zhenyu Yang3†, Chuan Li3†, Zhenning Wang4†, Meichen Li5†, Zhi Wei2*†, Yu Liu6, Xiuqi Wang6, Hongbin Lan6, Zhen Zeng3, Maodi Xie7, Yuan Xie1, Suwen Wu8, Wanming Hu9, Chengcheng Guo1, Xiangheng Zhang1, Lun Liang10, Chengwei Yu11, Yanhao Mou1, Yu Jiang12, Houde Li3, Eric Sugarman13, Rebecca A. Deek 14, Zexin Chen15, Tao Li7, Yaohui Chen3*†, Maojin Yao16*†, Likun Chen5*†, Lunxu Liu3*†, Gao Zhang6*† and Yonggao Mou1*†  \nAbstract  \nBackground Lung cancer brain metastases (LC-BrMs) are frequently associated with dismal mortality rates in patients with lung cancer; however, standard of care therapies for LC-BrMs are still limited in their efficacy. A deep understanding of molecular mechanisms and tumor microenvironment of LC-BrMs will provide us with new insights into developing novel therapeutics for treating patients with LC-BrMs.  \nMethods Here, we performed integrated analyses of genomic, transcriptomic, proteomic, metabolomic, and single-cell RNA sequencing data which were derived from a total number of 154 patients with paired and unpaired primary lung cancer and LC-BrM, spanning four published and two newly generated patient cohorts on both bulk and single cell levels.  \n\n| †Hao Duan, Jianlan Ren, Shiyou Wei, Zhenyu Yang, Chuan Li, Zhenning Wang and Meichen Li contributed equally to this work. |\n| --- |\n| †Zhi Wei, Yaohui Chen, Maojin Yao, Likun Chen, Lunxu Liu, Gao Zhang and Yonggao Mou are senior authors. |\n\n*Correspondence: Zhi Wei  \n[zhiwei@njit.edu](zhiwei@njit.edu)[ ](zhiwei@njit.edu)Yaohui Chen[yhchen@scu.edu.cn](yhchen@scu.edu.cn)[ ](yhchen@scu.edu.cn)Maojin Yao [maojin.yao@aliyun.com](maojin.yao@aliyun.com)[ ](maojin.yao@aliyun.com)Likun Chen[chenlk@sysucc.org.cn](chenlk@sysucc.org.cn)[ ](chenlk@sysucc.org.cn)Lunxu Liu [lunxu_liu@aliyun.com](lunxu_liu@aliyun.com)[ ](lunxu_liu@aliyun.com)Gao Zhang [gzhang6@me.com](gzhang6@me.com)[ ](gzhang6@me.com)Yonggao Mou [mouyg@sysucc.org.cn](mouyg@sysucc.org.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nDuan etal. Genome Medicine (2024) 16:138 Page 2 of 30  \nResults We uncovered that LC-BrMs exhibited a significantly greater intra-tumor heterogeneity. We also observed that mutations in a subset of genes were almost always shared by both primary lung cancers and LC-BrM lesions, including TTN, TP53, MUC16, LRP1B, RYR2, and EGFR. In addition, the genome-wide landscape of somatic copy number alterations was similar between primary lung cancers and LC-BrM lesions. Nevertheless, several regions of focal amplification were significantly enriched in LC-BrMs, including 5p15 .33 and 20q13 .33. Intriguingly, integrated analyses of t","cbCaieUvctDq8PPb","https://ap.wps.com/l/cbCaieUvctDq8PPb","pdf",5453041,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Background\n## Epidemiology and clinical burden of LC-BrMs","[{\"question\":\"What problem does the study address in lung cancer brain metastases?\",\"answer\":\"The study addresses the poor mortality associated with LC-BrMs and the limited efficacy of current standard-of-care therapies, emphasizing the need for better mechanistic understanding to enable new therapeutics.\"},{\"question\":\"What types of data were integrated, and how many patient samples were used?\",\"answer\":\"The authors performed integrated analyses of genomic, transcriptomic, proteomic, metabolomic, and single-cell RNA sequencing data from 154 patients, using four published and two newly generated patient cohorts across bulk and single-cell levels.\"},{\"question\":\"What major biological findings were reported for LC-BrMs?\",\"answer\":\"LC-BrMs showed greater intra-tumor heterogeneity, shared key mutations between primary tumors and metastases, and similar genome-wide copy-number landscapes with focal amplifications enriched in LC-BrMs. Integrated omics suggested activated mitochondrial-specific metabolism alongside suppressed tumor immune microenvironments.\"},{\"question\":\"How did the proposed therapeutic approach perform experimentally?\",\"answer\":\"Targeting oxidative phosphorylation with gamitrinib in patient-derived organoids induced apoptosis and reduced proliferation. The combination of gamitrinib plus anti-PD-1 immunotherapy improved survival in mice bearing LC-BrMs.\"}]","Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis - research open access | PDF",1790017605,76,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab058669a9cac8ccb3e36f515d3f77c1.webp",983,1305,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31e0ae3cd962ac9d3cfecbda62ffbabe.webp",982,1304,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca18b8149d26b8e03aa218e2f5ee8ecc.webp",981,1303,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db7fad795fc4be2182678e6aa404c031.webp",980,1301]